Cargando…
Rhabdomyolysis-induced acute kidney injury in a cancer patient exposed to denosumab and abiraterone: a case report
BACKGROUND: Denosumab and abiraterone were approved by the United States Food and Drug Administration in 2011 for the treatment of metastatic castration-resistant prostate cancer. Neither denosumab nor abiraterone is known to cause rhabdomyolysis. CASE PRESENTATION: A 76-year-old Caucasian man with...
Autores principales: | Neyra, Javier A., Rocha, Natalia A., Bhargava, Rhea, Vaidya, Omkar U., Hendricks, Allen R., Rodan, Aylin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519001/ https://www.ncbi.nlm.nih.gov/pubmed/26220655 http://dx.doi.org/10.1186/s12882-015-0113-6 |
Ejemplares similares
-
Collapsing Focal Segmental Glomerulosclerosis Resulting from a Single Dose of Zoledronate
por: Neyra, Javier A., et al.
Publicado: (2014) -
Hemodialysis catheter insertion: is increased PO(2) a sign of arterial cannulation? A case report
por: Chirinos, Julio C, et al.
Publicado: (2014) -
Abiraterone Acetate
Publicado: (2012) -
Sodium and magnesium in the distal convoluted tubule: no longer a couple?
por: Rodan, Aylin R.
Publicado: (2018) -
Rhabdomyolysis-associated Acute Kidney Injury
por: Subashri, Mohanasundaram, et al.
Publicado: (2023)